- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00513734
A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill
August 8, 2007 updated by: Barts & The London NHS Trust
Randomised Trial Comparing the Efficacy of Ocular Lubricant (Lacrilube) and Polyacrylamide Hydrogel Dressing (Geliperm) for the Prevention of Exposure Keratopathy in the Critically Ill
Corneal damage in critically ill patients is common.
There are currently two popular methods of treatment in the UK; hydrogel dressings and lubricating ointment.
We propose to randomise patients to have a different treatment for each eye and see which one is more effective.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Microbial keratitis, particularly pseudomonas-related, has been widely reported amongst Intensive therapy unit (ITU) patients and the need for effective eye care in ITU has been recognised for some time.
We compare two popular methods of eye care; a hydrogel dressing and lacrilube ointment.
Each recruited patient had each eye randomised to different treatments.
Daily ophthalmology ward rounds were undertaken to identify any corneal exposure keratopathy.
Patients were removed from the trial if one eye developed significant exposure needing treatment.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients admitted to Intensive care and expected to stay for more than 2 days
Exclusion Criteria:
- Primary orbital injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
Geliperm Hydrogel Dressing
|
3x3cm hydrogel dressing over closed eye
|
|
Active Comparator: 2
Lacrilube ointment
|
lubricant put into eye (inferior formix)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Development of clinically significant corneal exposure
Time Frame: throughout length of admission to ITU
|
throughout length of admission to ITU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Marie Healy, FRCA, Lead Clinicain, Dept. of Intensive Care Medicine, Royal London Hospital, London E1 1BB
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2004
Study Completion (Actual)
February 1, 2005
Study Registration Dates
First Submitted
August 8, 2007
First Submitted That Met QC Criteria
August 8, 2007
First Posted (Estimate)
August 9, 2007
Study Record Updates
Last Update Posted (Estimate)
August 9, 2007
Last Update Submitted That Met QC Criteria
August 8, 2007
Last Verified
August 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 003171
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratitis
-
Alexandria UniversityCompletedBacterial Keratitis | Fungal Keratitis | Mixed Bacterial and Fungal Keratitis | Microbial KeratitisEgypt
-
Assiut UniversityNot yet recruitingKeratitis | Microbial Keratitis
-
Minia UniversityRecruitingCorneal Ulcer | Bacterial Keratitis | Recalcitrant Infectious KeratitisEgypt
-
Chulalongkorn UniversityCompletedBacterial Keratitis | Infectious Keratitis | Fungal KeratitisThailand
-
Dompé Farmaceutici S.p.ACompletedNeurotrophic KeratitisUnited States
-
University of California, Los AngelesDompé Farmaceutici S.p.ACompleted
-
University of AlbertaWithdrawn
-
London Health Sciences Centre Research Institute...Not yet recruitingNeurotrophic KeratitisCanada
-
Krystal Biotech, Inc.RecruitingNeurotrophic KeratitisUnited States
-
IVIEW Therapeutics Inc.Not yet recruiting
Clinical Trials on Hydrogel dressing
-
Army Medical University, ChinaRecruiting
-
Magda BayoumiCompleted
-
Taipei Veterans General Hospital, TaiwanCompletedWounds and Injuries | Surgical Wound | Cesarean Section | Surgical Wound InfectionTaiwan
-
HealthpointCompletedDiabetic Foot Ulcers | Diabetic Foot WoundsUnited States, Canada
-
Lavior Pharma Inc.CompletedDiabetic Foot UlcerUnited States
-
University Hospital, CaenSociété de Dermatologie FrançaiseCompleted
-
Hospital Universitario de CanariasTerminatedWound Infection, SurgicalSpain
-
ULURU Inc.Terminated
-
King Edward Medical UniversityRecruitingPain, Postoperative | Donor Site Complication | Skin Transplantation | Skin Graft WoundsPakistan
-
Isfahan University of Medical SciencesNot yet recruitingTrauma WoundsIran, Islamic Republic of